MedTrace Logo

A Trial Evaluating Patient Preference of Dropless vs Drops Post Cataract Surgery

NCT04205916 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2019-12-20

No results posted yet for this study

Summary

To evaluate the safety and ocular efficacy of Dextenza in combination with an intracameral antibiotic and NSAID in controlling post-operative ocular pain and inflammation compared to standard of care topical therapy in patients undergoing bilateral cataract surgery.

Conditions

  • Patient Preference

Interventions

DRUG

Dexamethasone

Drugs to be administer during cataract surgery to experimental group

OTHER

Standard of care surgery

Standard method used for surgery and the use of post operative drops

Sponsors & Collaborators

  • Ocular Therapeutix, Inc.

    collaborator INDUSTRY

  • Ophthalmic Consultants of Long Island

    lead OTHER

Principal Investigators

  • Eric Donnenfeld, MD · Physician

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
22 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-04
Primary Completion
2020-06-30
Completion
2020-12-01
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04205916 on ClinicalTrials.gov